Search for: "WATSON PHARMACEUTICALS "
Results 161 - 180
of 359
Sort by Relevance
|
Sort by Date
4 Dec 2011, 9:38 am
Vestura, is manufactured by Watson Pharmaceuticals, containing ethinyl estradiol and drospirenone, a newer “fourth” generation progestin that is only found in the Yaz-family of contraceptives. [read post]
2 Dec 2011, 10:28 am
Watson Pharmaceuticals and Ranbaxy Laboratories both announced plans to distribute a generic version of atorvastatin containing the same active ingredients under its own brand. [read post]
1 Dec 2011, 2:02 pm
Coincidence, But Ironic, Given Several Recent Medical Studies Which Suggest Drospirenone (DRSP) Causes Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) On November 29, 2011 Watson Pharmaceuticals issued this press release, "Watson's Generic Yaz(R) Receives FDA Approval", which begins as follows: Watson Pharmaceuticals, Inc. [read post]
1 Dec 2011, 3:58 am
Ranbaxy's Lipitor-copy goes on sale 1 Dec 2011, but the impact on consumers is a bit more complicated than one might think.For example, Watson Pharmaceuticals is selling a Lipitor copy under an agreement made with patentee Pfizer (thus, an authorized generic). [read post]
8 Nov 2011, 8:15 am
And Judge Moreno ruled against Watson Pharmaceuticals in a big patent infringement case.Plus I only have 14 judicial fundraisers to attend this week. [read post]
5 Nov 2011, 4:17 am
In addition to Yaz and Yasmin the Washington Post identified these drosperinone-containing birth control pills: Bayer’s Beyaz and Safyral, Sandoz’s Syeda and Loryna, Barr Laboratories’ Ocella, Watson Pharmaceuticals’ Zarah, and Teva Pharmaceuticals’ Loryna. [read post]
3 Nov 2011, 9:55 am
Watson Pharmaceuticals, Inc., 629 F. [read post]
2 Nov 2011, 2:00 am
Teva Pharmaceuticals USA et al (Docket Report) US: Fred Hutchinson Cancer Research Center files patent infringement complaint against Branhaven over sales of Canine Heritage XL Breed Test (Patent Docs) Products Atelvia (Risedronate sodium delayed-release) – US: Warner Chilcott files patent infringement complaint against Watson in response to Para IV certification (Patent Docs) Butrans (Buprenorphine) – US: PTO says PTE not available in “reverse… [read post]
1 Nov 2011, 6:08 am
Birth-control pills containing drospirenone include Bayer’s Yaz, Yasmin, Beyaz, Safyral; Sandoz’s Syeda and Loryna; Barr Laboratories’ Ocella; Watson Pharmaceuticals’ Zarah; and Teva Pharmaceuticals' Loryna. [read post]
19 Oct 2011, 3:30 am
(IPBiz) US: Patent protection for the BRCA1 gene and genetic diagnostic methods in the USA: AMP v USPTO (JIPLP) US: Marking with an unenforceable patent does not create intent to deceive: Hollander v Hospira (Chicago Intellectual Property Law Blog) US: Regenerative Sciences lawsuit update and FDA’s attempt to broaden the definition of “interstate commerce”: USA v Regenerative Sciences (FDA Law Blog) Products Embeda (Morphine, Naltrexone) – US: Pfizer, Alpha… [read post]
18 Oct 2011, 1:32 am
Everyone in the industry benefits from Towers Watson’s annual survey, the summary report for which Tower Watson makes freely available. [read post]
14 Oct 2011, 6:10 pm
Orange County - Noven Pharmaceuticals, Inc. has filed an action for patent infringement against Watson Pharmaceuticals, Inc. in a federal district court in New Jersey. [read post]
10 Oct 2011, 10:00 am
Three generic versions of the drug, manufactured and marketed by Teva, Cephalon/Watson Pharmaceuticals, and Covidien, currently exist in the United States; this number would be reduced to two after Teva's acquisition of Cephalon. [read post]
9 Oct 2011, 9:37 pm
• Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc.; Watson Pharma Inc.; Watson Laboratories Inc. - Florida Infringement of U.S. [read post]
5 Oct 2011, 3:44 am
General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor v… [read post]
5 Oct 2011, 3:44 am
General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor v… [read post]
15 Sep 2011, 12:38 pm
Watson Pharmaceuticals and the Sandoz unit of Novartis AG are the latest companies to settle with the federal and several state governments as a result of ongoing litigation brought by Ven-A-Care of the Florida Keys alleging that several manufacturers overcharged Medicaid for prescription drugs by inflating their Average Wholesale Prices. [read post]
13 Sep 2011, 3:48 am
” The Towers Perrin / Towers Watson study, the sole source of most of these claims, remains discredited. [read post]
1 Sep 2011, 5:10 pm
As Justice Kennedy puts it: “the State defends the law by insisting that “pharmaceutical marketing has a strong influence on doctors’ prescribing practices. [read post]
25 Aug 2011, 3:42 pm
Watson said the fund could also include safe removal systems, medical research into improved diagnostic, treatment and patient care practices, and approaches to systems of compensation and support. [read post]
